We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Immune Molecules Expressed Inside Mycetoma Lesions

By LabMedica International staff writers
Posted on 24 Jul 2019
Mycetoma is a persistent, progressive granulomatous inflammatory disease caused either by fungi or by bacteria. More...
Characteristic of this disease is that the causative agents organize themselves in macroscopic structures called grains. These grains are surrounded by a massive inflammatory reaction.

Mycetoma is caused by any of 56 different microorganisms and is endemic to many tropical and subtropical areas. It usually affects young adults and children and is most common in farmers and other workers who deal directly with soil. Mycetoma appears as a slow-growing tumor-like mass that gradually increases in size.

A team of international scientists working with the University of Khartoum (Khartoum, Sudan) studied surgical biopsies from 100 patients with confirmed mycetoma. Surgical biopsies from these patients were fixed in 10% formalin for 24 hours, and paraffin blocks were prepared and all sections were stained with haematoxylin and eosin (H&E). Collagen fibers were detected in tissue sections by staining them in Weigert’s iron hematoxylin working solution for 10 minutes. Immunohistochemical staining was used to determine the matrix metalloprotease-9 (MMP-9) and Interleukin-17 (IL-17) expression around the grains of different mycetoma causatives agents. In Sudan, the most commonly encountered micro-organisms are the fungus Madurella mycetomatis and the bacteria Streptomyces somaliensis, Actinomadura madurae and Actinomadura pelletierii.

The scientists reported that while IL-17 was mostly found in Zones I and II of the grains, MMP-9 was present primarily in the more outer Zones II and III. Levels of the two immune molecules corresponded with each other, and were associated with the disease duration and lesion size. Moreover, levels of MMP-9 also varied by the causative agent of mycetoma and MMP-9 expression was detected as brown cytoplasmic stain within the cells. IL-17A expression was noticed within the cytoplasm of neutrophils, macrophages and lymphocyte cells. MMP-9 was more highly expressed in A. pelletierii and S. somaliensis biopsies compared to M. mycetomatis biopsies.

The authors concluded that their results obtained in the present study demonstrated that IL-17A and MMP-9 were expressed in the granuloma of different mycetoma causative agents and that the expression of IL-17A was more extensively in larger lesions and lesions with a longer disease duration. They also demonstrated a positive correlation between IL-17A expression levels and MMP-9 expression levels. The study was published on July 11, 2019, in the journal PLOS Neglected Tropical Diseases.

Related Links:
University of Khartoum


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Biochemical Analyzer
iBC 900
New
Staining Management Software
DakoLink
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.